UCB Ventures logo

UCB Ventures

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Description

UCB Ventures is a €150 million strategic corporate venture fund

Investor Profile

UCB Ventures has backed more than 18 startups, with 2 new investments in the last 12 months alone. The firm has led 8 rounds, about 44% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Belgium, Spain.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series A (44%)
  • Series B (22%)
  • Series Unknown (11%)
  • Seed (11%)
  • Series E (6%)
  • Series F (6%)

Country Focus

  • United States (67%)
  • Belgium (17%)
  • Spain (11%)
  • United Kingdom (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science
  • Pharmaceutical
  • Information Technology
  • Biopharma
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UCB Ventures frequently co-invest with?

CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
EC
North America, New York, United States, New York
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 4
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 3
BF
North America, California, United States, Berkeley
Co-Investments: 2
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
The Column Group
North America, California, United States, San Francisco
Co-Investments: 3
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 3
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3

What are some of recent deals done by UCB Ventures?

Splice Bio

Barcelona, Catalonia, Spain

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

BiotechnologyLife ScienceMedicalPharmaceutical
Series BJun 11, 2025
Amount Raised: $135,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series EFeb 8, 2024
Amount Raised: $120,000,000
ViaNautis

Cambridge, Cambridgeshire, United Kingdom

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

BiopharmaBiotechnologyMedical
Series ANov 13, 2023
Amount Raised: $24,558,590
Switch Therapeutics

San Francisco, California, United States

Switch Therapeutics is a biotech company that develops RNAi therapies.

BiotechnologyMedicalTherapeutics
Series AMar 14, 2023
Amount Raised: $52,000,000
Code Biotherapeutics

Hatfield, Pennsylvania, United States

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

BiotechnologyHealth CareLife Science
Series AJun 7, 2022
Amount Raised: $75,000,000
Splice Bio

Barcelona, Catalonia, Spain

Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University.

BiotechnologyLife ScienceMedicalPharmaceutical
Series AFeb 15, 2022
Amount Raised: $56,776,503
EsoBiotec

Mont-saint-guibert, Brabant Wallon, Belgium

soBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.

Biotechnology
SeedSep 30, 2021
Amount Raised: $3,472,351
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series UnknownJun 22, 2021
Amount Raised: $41,500,000
Rinri Therapeutics

Sheffield, Massachusetts, United States

Rinri Therapeutics is a biotechnology company developing a novel cell-based therapy.

BiotechnologyMedical
Series UnknownApr 20, 2021
Amount Raised: $12,032,507